Sherman EJ - Search Results

1

Phase 2 Trial of Regorafenib in Recurrent/Metastatic Adenoid Cystic Carcinoma.

Desilets A, Vos JL, Katabi N, Kuo F, Nadeem Z, Linxweiler M, Ostrovnaya I, Baxi S, Dunn LA, Sherman EJ, Pfister DG, Morris LGT, Ho AL. Desilets A, et al. Among authors: sherman ej. Clin Cancer Res. 2024 Dec 2;30(23):5281-5292. doi: 10.1158/1078-0432.CCR-24-1064. Clin Cancer Res. 2024. PMID: 39352719 Clinical Trial.

2

Clinical economics of head and neck malignancies.

Sherman EJ, Ruchlin HS, Holden JS, Pfister DG. Sherman EJ, et al. Hematol Oncol Clin North Am. 1999 Aug;13(4):867-81. doi: 10.1016/s0889-8588(05)70098-8. Hematol Oncol Clin North Am. 1999. PMID: 10494519 Review.

3

The Collection of Indirect and Nonmedical Direct Costs (COIN) form: a new tool for collecting the invisible costs of androgen independent prostate carcinoma.

Sherman EJ, Pfister DG, Ruchlin HS, Rubin DM, Radzyner MH, Kelleher GH, Slovin SF, Kelly WK, Scher HI. Sherman EJ, et al. Cancer. 2001 Feb 15;91(4):841-53. Cancer. 2001. PMID: 11241254 Clinical Trial.

4

A new intensified therapeutic regimen for advanced head and neck squamous cell carcinomas: where does it fit among available treatment options?

Pfister DG, Sherman EJ, Wolden SL. Pfister DG, et al. Among authors: sherman ej. Cancer Invest. 2001;19(2):217-8. doi: 10.1081/cnv-100000157. Cancer Invest. 2001. PMID: 11296625 No abstract available.

5

Prediction of survival in patients with head and neck cancer using the histoculture drug response assay.

Singh B, Li R, Xu L, Poluri A, Patel S, Shaha AR, Pfister D, Sherman E, Goberdhan A, Hoffman RM, Shah J. Singh B, et al. Head Neck. 2002 May;24(5):437-42. doi: 10.1002/hed.10066. Head Neck. 2002. PMID: 12001073

6

Alteration of p53 pathway in squamous cell carcinoma of the head and neck: impact on treatment outcome in patients treated with larynx preservation intent.

Osman I, Sherman E, Singh B, Venkatraman E, Zelefsky M, Bosl G, Scher H, Shah J, Shaha A, Kraus D, Cordon-Cardo C, Pfister DG. Osman I, et al. J Clin Oncol. 2002 Jul 1;20(13):2980-7. doi: 10.1200/JCO.2002.06.161. J Clin Oncol. 2002. PMID: 12089228

7

Using patients as their own controls for cost evaluation of phase I clinical trials.

Sherman EJ, Rubin DM, Venkatraman E, Schwartz GK, Miller VA, Radzyner MH, Ruchlin HS, Spriggs D, Pfister DG. Sherman EJ, et al. J Clin Oncol. 2004 Apr 1;22(7):1308-14. doi: 10.1200/JCO.2004.06.118. J Clin Oncol. 2004. PMID: 15051779 Clinical Trial.

8

Identification of angiogenesis/metastases genes predicting chemoradiotherapy response in patients with laryngopharyngeal carcinoma.

Ganly I, Talbot S, Carlson D, Viale A, Maghami E, Osman I, Sherman E, Pfister D, Chuai S, Shaha AR, Kraus D, Shah JP, Socci ND, Singh B. Ganly I, et al. J Clin Oncol. 2007 Apr 10;25(11):1369-76. doi: 10.1200/JCO.2005.05.3397. J Clin Oncol. 2007. PMID: 17416856

9

Concurrent cisplatin and radiation versus cetuximab and radiation for locally advanced head-and-neck cancer.

Koutcher L, Sherman E, Fury M, Wolden S, Zhang Z, Mo Q, Stewart L, Schupak K, Gelblum D, Wong R, Kraus D, Shah J, Zelefsky M, Pfister D, Lee N. Koutcher L, et al. Int J Radiat Oncol Biol Phys. 2011 Nov 15;81(4):915-22. doi: 10.1016/j.ijrobp.2010.07.008. Epub 2010 Oct 13. Int J Radiat Oncol Biol Phys. 2011. PMID: 20947269

10

Systemic therapy in the management of metastatic or locally recurrent adenoid cystic carcinoma of the salivary glands: a systematic review.

Laurie SA, Ho AL, Fury MG, Sherman E, Pfister DG. Laurie SA, et al. Lancet Oncol. 2011 Aug;12(8):815-24. doi: 10.1016/S1470-2045(10)70245-X. Epub 2010 Dec 10. Lancet Oncol. 2011. PMID: 21147032 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

175 results

Search Page

Filters